Home > Healthcare > Medical Devices > Implantable Devices > Implantable Loop Recorders Market

Implantable Loop Recorders Market – By Product Type (Automatic Recorders, Manual Recorders), Application (Atrial Fibrillation, Cardiac Arrhythmia, Cardiac Syncope), End-use (Hospitals, Cardiac Centers, ASCs) – Global Forecast (2024 – 2032)

  • Report ID: GMI8517
  • Published Date: Mar 2024
  • Report Format: PDF

Implantable Loop Recorders Market Size

Implantable Loop Recorders Market was valued at around USD 1.4 billion in 2023 and is estimated to register a CAGR of 8.2% over the forecast period. This robust market growth can be attributed to various factors, including ongoing advancements in implantable loop recorder (ILR) technology, increasing prevalence of cardiac arrhythmias, rising demand for remote monitoring solutions, growing awareness about cardiac health, and the continual growth of healthcare expenditure, among other contributing factors.
 

Implantable Loop Recorders Market

Implantable loop recorders (ILR) are a small, implantable medical device designed to continuously monitor and record the electrical activity of the heart over an extended period. It is typically used for the diagnosis and monitoring of cardiac arrhythmias, including atrial fibrillation, bradycardia, tachycardia, and syncope (fainting). The increasing prevalence of cardiac arrhythmias, such as atrial fibrillation, ventricular arrhythmias, and bradyarrhythmias is driving up demand for ILRs. The demand for efficient diagnostic and monitoring methods to identify and treat arrhythmias growing owing to the aging global population and a rising incidence of cardiovascular disease. For instance, according to the American Heart Association, Inc. approximately 3 to 6 million Americans suffer with atrial fibrillation, and by 2050, the number is anticipated to rise to 6 to 16 million. Hence ILRs are becoming an essential device in cardiac care.

Furthermore, continuous advancements in ILR technology have led to the development of smaller, more sophisticated devices with enhanced monitoring capabilities. Improved battery life, wireless connectivity, and remote monitoring features have made ILRs more convenient for both patients and healthcare providers. As technology continues to evolve, ILRs are becoming more reliable, accurate, and user-friendly, driving their adoption in clinical practice, thereby contributing to the market growth.
 

Implantable Loop Recorders Market Trends

The implantable loop recorders industry is experiencing several notable trends that are shaping its growth and development. Factors such as technological innovation in ILR design, growing adoption of remote monitoring and telemedicine solutions, rising prevalence of cardiovascular disease, and surging demand for integrated artificial intelligence (AI) in healthcare and machine learning, among other factors are propelling the industry growth.
 

  • Further, the increasing adoption of remote monitoring and telemedicine solutions is driving demand for ILRs with remote monitoring capabilities. Remote monitoring allows healthcare providers to remotely access and review patients' cardiac data, reducing the need for frequent in-person clinic visits and enabling proactive management of cardiac arrhythmias. Telemedicine platforms facilitate virtual consultations, enabling patients to receive personalized care and support from healthcare providers without the need for face-to-face appointments.
     
  • Moreover, the shift towards value-based care and outcomes-driven healthcare models is driving the adoption of ILRs as part of comprehensive care management strategies. ILRs enable early detection of cardiac arrhythmias, facilitating timely intervention and preventing adverse cardiovascular events, thereby improving patient outcomes, and reducing healthcare costs associated with hospitalizations and emergency department visits.
     

Implantable Loop Recorders Market Analysis

Implantable Loop Recorders Market, By Product Type, 2021 – 2032 (USD Billion)

The market by product type is categorized into automatic recorders and manual recorders. The automatic recorders segment garnered USD 958.6 million revenue in 2023.
 

  • Automatic recorders enhance diagnostic accuracy by continuously monitoring the heart's electrical activity over an extended period, allowing for the detection of asymptomatic or infrequent arrhythmias that may go unnoticed with conventional monitoring methods. By capturing and recording data automatically, these devices provide comprehensive insights into a patient's cardiac rhythm patterns, facilitating accurate diagnosis and treatment planning.
     
  • Furthermore, these devices enable early detection of cardiac arrhythmias, including atrial fibrillation, ventricular tachycardia, and bradyarrhythmias, which are associated with an increased risk of adverse cardiovascular events such as stroke, heart failure, and sudden cardiac death. Timely identification of arrhythmias allows healthcare providers to initiate appropriate interventions, such as anticoagulation therapy or cardiac device implantation, to mitigate the risk of complications and improve patient outcomes. This is anticipated to boost the segmental growth in the market positively.
     
Implantable Loop Recorders Market, By Application (2023)

Based on application, the implantable loop recorders market is segmented into atrial fibrillation, cardiac syncope, cardiac arrhythmia, and other applications. The atrial fibrillation segment dominated the market and accounted for over 42.3% market share in 2023 and is anticipated to witness significant growth during the forecast period.
 

  • Atrial fibrillation is one of the most prevalent cardiac arrhythmias globally, with its prevalence increasing significantly with age. As the population ages and the prevalence of risk factors such as hypertension, diabetes, obesity, and valvular heart disease rises, the overall burden of atrial fibrillation is expected to escalate. The increasing prevalence of atrial fibrillation drives the demand for diagnostic and monitoring solutions, including ILRs, to effectively manage the condition and reduce associated risks.
     
  • Moreover, there is an increasing recognition of the heterogeneity of atrial fibrillation and the importance of personalized treatment approaches tailored to individual patient characteristics and risk profiles. ILRs facilitate personalized treatment decisions by providing comprehensive data on patients' cardiac rhythm patterns, enabling healthcare providers to identify appropriate treatment strategies based on the severity and frequency of atrial fibrillation episodes, comorbidities, and patient preferences.
     

The implantable loop recorders industry by end-use is categorized into hospitals, cardiac centers, ambulatory surgical centers, and other end-users. The hospitals segment accounted for around USD 814.4 million revenue size in 2023.
 

  • Hospitals are increasingly adopting patient-centered care models that prioritize personalized treatment approaches and proactive patient management strategies. ILRs enable hospitals to tailor treatment plans based on individual patient needs, preferences, and clinical characteristics, enhancing patient satisfaction and engagement in their healthcare management.
     
  • Additionally, the continuous advancements in cardiac monitoring technology, including ILRs, have expanded hospitals' diagnostic capabilities for cardiac arrhythmias and related conditions. Hospitals seek innovative solutions to enhance their diagnostic accuracy and patient care outcomes. ILRs offer continuous and long-term monitoring of cardiac rhythms, providing valuable insights into patients' cardiovascular health, thereby fostering segmental growth in the market.
     
North America Implantable Loop Recorders Market, 2020 – 2032 (USD Million)

North America implantable loop recorders market accounted for USD 536.7 million revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

  • North America has a high prevalence of cardiovascular disease, including cardiac arrhythmias such as atrial fibrillation, ventricular tachycardia, and bradyarrhythmias. As the leading cause of morbidity and mortality in the region, cardiovascular disease drives the demand for advanced cardiac monitoring technologies, including ILRs, to effectively diagnose, monitor, and manage cardiac arrhythmias and related conditions.
     
  • Furthermore, the region is a hub for technological advancements and innovation in the healthcare sector. The region is home to leading medical device companies, research institutions, and academic centers that drive innovation in ILR technology. Continuous advancements in ILR design, functionality, and performance, including improvements in device miniaturization, remote monitoring capabilities, and data analytics, enhance the diagnostic accuracy, usability, and patient outcomes associated with ILRs.
     

Implantable Loop Recorders Market Share

The implantable loop recorders industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy.
 

Implantable Loop Recorders Market Companies

Some of the eminent market participants operating in the implantable loop recorders industry include:

  • Abbott Laboratories
  • Angel Medical Systems, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Vectorious
     

Implantable Loop Recorders Industry News:

  • In July 2021, Abbott has announced the launch of Jot Dx, the company's latest implantable cardiac monitor (ICM), in the U.S. Through a unique feature that allows them to analyse all irregular heart rhythm data. With the use of the advanced technology, patients with cardiac arrhythmias can be detected remotely and have their increased diagnostic accuracy.
     

Implantable loop recorders market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments:

Click here to Buy Section of this Report


Market, By Product Type

  • Automatic recorders
  • Manual recorders

Market, By Application

  • Atrial fibrillation
  • Cardiac syncope
  • Cardiac arrhythmia
  • Other applications

Market, By End-use

  • Hospitals
  • Cardiac centers
  • Ambulatory surgical centers
  • Other end-users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East and Africa
       
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market size for implantable loop recorders was valued at around USD 1.4 billion in 2023 and is estimated to reach over USD 2.9 million by 2032, attributed ongoing advancements in implantable loop recorder (ILR) technology and increasing prevalence of cardiac arrhythmias.

Automatic recorders segment of implantable loop recorders industry garnered USD 958.6 million revenue in 2023 and is expected to grow swiftly till 2032, as they enhance diagnostic accuracy by continuously monitoring the heart's electrical activity, enabling the detection of asymptomatic or infrequent arrhythmias that conventional methods may miss.

North America market accounted for USD 536.7 million in 2023 and is predicted to grow substantially through 2032, owing to a high prevalence of cardiovascular disease, including cardiac arrhythmias such as atrial fibrillation, ventricular tachycardia, and bradyarrhythmias.

Abbott Laboratories, Angel Medical Systems, Inc., Biotronik, Boston Scientific Corporation, GE Healthcare, Koninklijke Philips N.V., Medtronic plc, MicroPort Scientific Corporation, Nihon Kohden Corporation, Vectorious are some of the major industry contenders.

Implantable Loop Recorders Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 203
  • Countries covered: 22
  • Pages: 100
 Download Free Sample